Latest Regulatory Approval News

Neuren Pharmaceuticals reports a 16% rise in Q2 2025 royalties driven by Acadia’s DAYBUE sales growth and expanding patient base in the US. Full-year sales guidance remains strong with European market entry on the horizon.

Silex Systems Limited has announced a $145 million equity raise to fund the commercialisation of its SILEX laser uranium enrichment technology through its US joint venture, Global Laser Enrichment. The capital will support critical technology milestones and expansion into new isotope markets amid a global nuclear fuel renaissance.

Silex Systems has raised $130 million through an institutional placement to advance its SILEX uranium enrichment technology in the US, bolstering its financial position through FY2028.

Atomo Diagnostics has secured a US$410,000 order from Lumos Diagnostics for its Pascal test cassettes, following Lumos's exclusive six-year US distribution deal for the FebriDx test with PHASE Scientific.

Light & Wonder reported solid Q2 earnings growth and margin expansion despite slight revenue dip, completed Grover acquisition ahead of schedule, and announced plans to delist from Nasdaq for a sole ASX listing by November 2025.

Locksley Resources has completed an oversubscribed capital raising and appointed Tribeca Capital to drive its U.S.-focused critical minerals strategy, targeting rare earths and antimony supply chains aligned with government initiatives.

Toys"R"Us ANZ has formalised a Deed of Company Arrangement, paving the way for Directed Electronics Australia to acquire the company and trigger its delisting from the ASX.

Infomedia Limited has struck a deal with TPG Capital Asia to be acquired at $1.72 per share, offering shareholders a 41% premium over recent trading prices. The scheme includes fully franked dividends, potentially raising the effective value to $1.74 per share for eligible investors.

News Corporation has announced an ordinary dividend of USD 0.10 per Class B Voting Common Stock-CDI, payable in October 2025 with key dates set for September. The dividend is unfranked and subject to withholding tax, with payments in USD and AUD depending on the security held.

Manuka Resources has successfully completed a fully underwritten entitlement offer, raising nearly $8 million before costs, supplemented by an additional placement to sub-underwriters and creditors.

Brightstar Resources has unveiled a robust multi-hub expansion strategy in Western Australia, boosted by its strategic acquisition of Aurumin Limited. The company targets a significant production increase to 200,000 ounces of gold annually by 2029.

Vitrafy Life Sciences reported a 75% increase in FY25 sales driven by aquaculture and human health sectors, progressing its cryopreservation technology towards commercialisation in both unregulated and regulated markets in FY26.